TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT05103254: Bempedoic Acid Pregnancy Surveillance Program

Sponsor: Esperion Therapeutics, Inc. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 20 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$2,988,000

Rescue Site Savings

+$1,958,800

Unlock Full NCT05103254 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05103254 Rescue Dossier →